Acetazolamide-Responsive Ataxia

Abstract

Acetazolamide-responsive ataxia represents a unique collection of genetically distinct episodic ataxia (EA) disorders associated with paroxysmal cerebellar symptoms many of which are responsive to medical treatment with acetazolamide, a carbonic anhydrase inhibitor. Among all of the subtypes of episodic ataxia, types 2 (EA2), 3 (EA3), and 5 (EA5) are thought be the most medication responsive. Some patients with episodic ataxia type 1 (EA1) will also describe improvement with acetazolamide. Each of these individual genetic syndromes is characterized by its own unique mechanism and clinical presentation. In this review, the author provides an overview of the pathophysiology of acetazolamide-responsive ataxia, its natural history, and its clinical management.

Keywords

acetazolamide - episodic ataxia - autosomal dominant - cerebellum - channelopathy - 4-aminopyridine

• References

• 1 Parker HL. Periodic ataxia. Collect Papers Mayo Clinic Mayo Found 1946– 1947; 38: 642-645
• 2 Griggs RC, Moxley III RT, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978; 28 (12) 1259-1264
• 3 Griggs RC, Nutt JG. Episodic ataxias as channelopathies. Ann Neurol 1995; 37 (3) 285-287
• 4 Zasorin NL, Baloh RW, Myers LB. Acetazolamide-responsive episodic ataxia syndrome. Neurology 1983; 33 (9) 1212-1214
• 5 Litt M, Kramer P, Browne D , et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 1994; 55 (4) 702-709
• 6 Browne DL, Gancher ST, Nutt JG , et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994; 8 (2) 136-140
• 7 Kramer PL, Yue Q, Gancher ST , et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am J Hum Genet 1995; 57 (1) 182-185
• 8 von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 1995; 4 (2) 279-284
• 9 Ophoff RA, Terwindt GM, Vergouwe MN , et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87 (3) 543-552
• 10 Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW. CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007; 130 (Pt 10) 2484-2493
• 11 Browne DL, Brunt ER, Griggs RC , et al. Identification of two new KCNA1 mutations in episodic ataxia/myokymia families. Hum Mol Genet 1995; 4 (9) 1671-1672
• 12 D'Adamo MC, Hanna MG, Di Govanni G , et al. Episodic ataxia type 1. GeneReviews 2010Feb9. Available from: http://www.ncbi.nlm.nih.gov/books/NBK25442/
• 13 Zuberi SM, Eunson LH, Spauschus A , et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999; 122 (Pt 5) 817-825
• 14 Eunson LH, Rea R, Zuberi SM , et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000; 48 (4) 647-656
• 15 Kinali M, Jungbluth H, Eunson LH , et al. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent episodic ataxia. Neuromuscul Disord 2004; 14 (10) 689-693
• 16 Spacey S. Episodic ataxia type 2. GeneReviews 2003Feb24. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1501/
• 17 Ducros A, Denier C, Joutel A , et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001; 345 (1) 17-24
• 18 Zhuchenko O, Bailey J, Bonnen P , et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15 (1) 62-69
• 19 Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997; 41 (1) 8-16
• 20 Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 2005; 62 (2) 314-316
• 21 Vighetto A, Froment JC, Trillet M, Aimard G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol 1988; 45 (5) 547-549
• 22 Baloh RW. Episodic ataxias 1 and 2. Handb Clin Neurol 2012; 103: 595-602
• 23 Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 2001; 57 (8) 1499-1502
• 24 Cader MZ, Steckley JL, Dyment DA, McLachlan RS, Ebers GC. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 2005; 65 (1) 156-158
• 25 Escayg A, De Waard M, Lee DD , et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000; 66 (5) 1531-1539
• 26 Damji KF, Allingham RR, Pollock SC , et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol 1996; 53 (4) 338-344
• 27 Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005; 65 (4) 529-534
• 28 Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 1998; 65 (4) 565-568
• 29 von Brevern M, Ta N, Shankar A , et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 2006; 46 (7) 1136-1141
• 30 Terwindt GM, Ophoff RA, van Eijk R , et al; Dutch Migraine Genetics Research Group. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001; 56 (8) 1028-1032
• 31 Bickler PE, Litt L, Banville DL, Severinghaus JW. Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol 1988; 65 (1) 422-427
• 32 Bain PG, O'Brien MD, Keevil SF, Porter DA. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 1992; 31 (2) 147-154
• 33 Sappey-Marinier D, Vighetto A, Peyron R, Broussolle E, Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol 1999; 46 (2) 256-259
• 34 Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics 2007; 4 (2) 267-273
• 35 Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol 2004; 56 (2) 213-220
• 36 Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004; 62 (1) 17-22
• 37 Strupp M, Kalla R, Claassen J , et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 2011; 77 (3) 269-275
• 38 Hess E. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 2011; 77 (22) 1996-1997 , author reply 1997